Dakota Wealth Management’s ResMed RMD Stock Holding History

Dakota Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.91M	Sell	9,800 -773	-7%	-$160K	0.04%	318
2026 Q1	$2.37M	Sell	10,573 -23,375	-69%	-$5.83M	0.05%	260
2025 Q4	$8.18M	Buy	33,948 +7,651	+29%	+$1.96M	0.15%	124
2025 Q3	$7.2M	Buy	26,297 +8,094	+44%	+$2.21M	0.15%	127
2025 Q2	$4.7M	Buy	18,203 +3,014	+20%	+$719K	0.1%	165
2025 Q1	$3.4M	Buy	15,189 +2,709	+22%	+$632K	0.08%	186
2024 Q4	$2.85M	Buy	+12,480	New	+$3M	0.07%	218
2023 Q4	–	Sell	-1,368	Closed	-$202K	–	700
2023 Q3	$202K	Sell	1,368 -1,669	-55%	-$302K	0.01%	597
2023 Q2	$664K	Buy	3,037 +1,269	+72%	+$283K	0.03%	330
2023 Q1	$387K	Sell	1,768 -1,042	-37%	-$226K	0.03%	416
2022 Q4	$585K	Buy	2,810 +43	+2%	+$9.45K	0.04%	320
2022 Q3	$604K	Sell	2,767 -633	-19%	-$144K	0.05%	307
2022 Q2	$713K	Buy	+3,400	New	+$724K	0.07%	232

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Dakota Wealth Management's RMD Position: Q2 2026 in Review

Dakota Wealth Management reduced its ResMed (RMD) stake by 7.3% in Q2 2026, selling an estimated $160K and leaving 9,800 shares worth $1.91M. The position accounts for 0.04% of the portfolio, ranked #318.

Dakota Wealth Management first reported a position in RMD in Q2 2022 and has held it in 13 quarters since. The position peaked at $8.18M in Q4 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Dakota Wealth Management held 9,800 shares of ResMed worth $1.91M as of Q2 2026.
Dakota Wealth Management sold 773 ResMed shares in Q2 2026, an estimated $160K.
ResMed made up 0.04% of Dakota Wealth Management's portfolio in Q2 2026, its #318 holding.
Dakota Wealth Management first reported a position in ResMed in Q2 2022 and has held it in 13 quarters since.
Dakota Wealth Management's ResMed position peaked at $8.18M in Q4 2025.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Dakota Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.